Mortality in patients who discontinue low-dose acetylsalicylic acid therapy after upper gastrointestinal bleeding

详细信息    查看全文

• 作者：Antonio Gonzá ; lez-P&eacute ; rez ; Marí ; a Eugenia Sá ; ez ; Saga Johansson ; P&eacute ; ter Nagy and Luis A. Garcí ; a Rodrí ; guez
• 刊名：Pharmacoepidemiology and Drug Safety
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：26
• 期：2
• 页码：215-222
• 全文大小：182K
• ISSN：1099-1557

文摘

Discontinuing low-dose acetylsalicylic acid (ASA) therapy after upper gastrointestinal bleeding (UGIB) may increase the risk of cardiovascular-related death. Our aim was to compare mortality in UK primary care patients who discontinue ASA after UGIB with that in patients who continue therapy.